The North America Enteral Nutrition Market is driven by the growing incidence of neurological disorders, cancer, gastrointestinal conditions, and other diseases requiring specialized nutritional support. North America is witnessing increasing demand for enteral nutrition solutions as healthcare providers focus on nutritional support for patients who cannot obtain adequate nutrition through conventional oral intake.
The Enteral Nutrition Market is projected to grow from US$10,584.80 million in 2024 to US$17,330.87 million by 2031, registering a CAGR of 7.3% during 2025–2031. The industry is witnessing increased demand for disease-specific formulations, plant-based products, ready-to-use nutritional solutions, and advanced enteral feeding technologies. The report covers historical data from 2021 to 2023, with 2024 as the base year and 2025 to 2031 as the forecast period.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00004763
Rising Prevalence of Chronic Diseases and Malnutrition Drives Growth
The increasing burden of gastrointestinal, neurological, oncological, renal, and liver diseases is a major growth driver. Gastrointestinal disorders such as Crohn's disease, ulcerative colitis, bowel obstruction, and short bowel syndrome can interfere with nutrient absorption and normal food intake. Patients undergoing intensive treatment or diagnostic procedures may also experience nutritional deterioration, creating a need for clinically appropriate nutritional support.
Malnutrition represents another significant factor. According to the reference analysis, malnutrition affects a substantial proportion of hospitalized patients, older adults, oncology patients, and intensive care patients. Enteral feeding provides an effective route for delivering essential calories, proteins, vitamins, and minerals when oral intake is inadequate but gastrointestinal function remains available.
The aging population further supports demand. Older adults frequently experience chronic diseases, swallowing difficulties, reduced appetite, and impaired nutrient absorption. As healthcare systems increasingly emphasize early nutritional intervention, the adoption of enteral nutrition products is expected to expand across institutional and home-care environments.
Product Innovation and Disease-Specific Formulations Create Opportunities
Product innovation is reshaping the competitive landscape. Manufacturers are developing specialized formulations designed for specific clinical conditions, nutritional requirements, and patient demographics. Disease-specific products can support patients with renal disease, liver disorders, gastrointestinal conditions, cancer, and neurological disorders.
The nasogastric segment accounted for the largest share, at 44.9% in 2024, reflecting widespread utilization of nasogastric feeding for patients requiring short-term nutritional support. Within nasogastric products, disease-specific formulations are anticipated to record strong growth during the forecast period.
Plant-based nutrition is another emerging opportunity. Consumers and healthcare providers are increasingly interested in formulations that align with plant-focused dietary preferences while maintaining appropriate nutritional profiles. The introduction of plant-based ready-to-drink products demonstrates how manufacturers are expanding beyond conventional formulations.
Strategic acquisitions and product launches are also strengthening portfolios. Danone's acquisition of Functional Formularies in May 2024 expanded its whole-food tube-feeding capabilities in the US, while Nutricia's introduction of Fortimel PlantBased Energy illustrates the growing focus on plant-based nutritional solutions.
Gastrointestinal Disorders and Pediatric Nutrition Gain Attention
By application, gastrointestinal disorders held the largest share, accounting for 30.2% in 2024. The high prevalence of digestive disorders and their direct effect on nutrient absorption and dietary intake continue to support demand for enteral nutritional products.
Oncology and neurology are also important application areas. Cancer patients may experience appetite loss, treatment-related complications, swallowing difficulties, and increased nutritional requirements. Similarly, neurological disorders can impair swallowing and feeding capabilities, making enteral nutritional support essential for some patients.
By age group, adults represented the larger segment in 2024. However, the pediatric segment is projected to grow at the fastest CAGR of 8.2% during 2025–2031. Premature births, congenital disorders, developmental conditions, and pediatric diseases can create specialized nutritional requirements. Manufacturers are therefore focusing on formulations and feeding solutions designed for infants and children.
Distribution is also evolving. Hospital pharmacies represented 53.6% of the share in 2024, supported by high utilization in inpatient care. At the same time, retail stores and e-commerce platforms are expanding access to nutritional products for patients receiving long-term care at home.
Regional Landscape and Competitive Environment
North America dominated the Enteral Nutrition Market with a 40.8% share in 2024. The region benefits from advanced healthcare infrastructure, high awareness of medical nutrition, an aging population, and significant demand from patients with chronic diseases. The US remains a major contributor, with its growth supported by increasing demand for specialized nutritional products among patients with obesity, diabetes, neurological conditions, and other chronic illnesses.
Asia Pacific is expected to register a strong 7.8% CAGR during 2025–2031. Rising healthcare expenditure, expanding hospital infrastructure, increasing awareness of clinical nutrition, and the growing burden of chronic diseases are creating opportunities across China, India, Japan, Australia, and other countries.
Key players operating in the industry include:
- Nestlé
- Danone S.A.
- Abbott Laboratories
- Fresenius SE & Co. KGaA
- B. Braun SE
- FrieslandCampina
- Arla Foods
- Reckitt Benckiser
- Perrigo Company PLC
- Fonterra Co-operative Group Limited
- Kate Farms
- Nutritional Medicinals, LLC
These companies are pursuing product launches, acquisitions, partnerships, portfolio expansion, and geographic expansion to strengthen their positions. Competition is increasingly centered on formulation quality, clinical specificity, convenience, distribution reach, and innovation in feeding technologies.
Future Outlook
Rising malnutrition, chronic disease prevalence, population aging, and demand for personalized nutritional support will remain central growth factors. Future opportunities are likely to emerge from disease-specific formulations, plant-based nutrition, pediatric products, ready-to-use solutions, and digitally enabled home-care services. As healthcare providers increasingly recognize nutrition as an integral component of disease management and recovery, innovation and strategic collaboration will remain critical to long-term industry growth.
Related Report:
1) Alzheimer's Drugs Market Analysis, Trends, and Forecast (2025-2031)
2) Patient-Derived Xenograft Model Market Size & Forecast 2031
3) Bioprocessing Market Analysis and Opportunities by 2031
About Us -
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish